SPY420.86+5.94 1.43%
DIA338.78+5.82 1.75%
IXIC14,141.48+111.10 0.79%

Aligos Therapeutics Q1 EPS $(0.74) Beats $(0.90) Estimate, Sales $910.00K

Aligos Therapeutics (NASDAQ:ALGS) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(0.90) by 17.78 percent. The company reported $910.00 thousand in sales this quarter.

05/10/2021 16:40
Aligos Therapeutics (NASDAQ:ALGS) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(0.90) by 17.78 percent. The company reported $910.00 thousand in sales this quarter.